TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab.

Tianle Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.